IP Library Granted Patent US 10,393,736
Granted Patent B2
US 10,393,736 · App. 15/476,722 · Granted Aug 27, 2019

Anti-fouling saline and siloxane coated particles, substrates, polymers and uses related thereto

Inventors: Hui Mao (Johns Creek, GA); Yuancheng Li (Atlanta, GA); Lily Yang (Atlanta, GA)
Assignees: Emory University; Children's Healthcare of Atlanta, Inc.
G01N33/54346C08G77/46C12N13/00G01N33/54393G01N33/57492C07F7/081C08G65/336C09C1/3081
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,393,736
App. No.
15/476,722
Granted
Aug 27, 2019
Kind
B2
Abstract

This disclosure relates to polymer coatings with desirable anti-fouling properties. In certain embodiments, polymers are coated on particles which allow for conjugation with targeting moieties. In certain embodiments, the particles are nanoparticles with targeting moieties that bind with tumor associated antigens.

Claims (44)

1. A polymer having the following formula:

wherein p is 1 to 10,000;

m is 1 to 22;

X is —CH(OH)CH 2 OCH 2 CH 2 CH 2 S—;

n=0, 1, 2;

R is an alkyl group, and

R′ is alkyl group.

2. A polymer having the following formula:

wherein R is alkyl and n is 1 to 10,000 or derivative thereof.

3. A substrate coated with a polymer made by the process of mixing a substrate and the polymer under conditions such that a siloxane-coated substrate is formed, wherein the polymer has the following formula:

wherein p is 1 to 10,000;

m is 1 to 22;

X is —CH(OH)CH 2 OCH 2 CH 2 CH 2 S—;

n=0, 1, 2;

R is an alkyl group, and

R′ is alkyl group.

4. A particle coated with a polymer made by the process of mixing a particle and the polymer under conditions such that a siloxane-coated particle is formed wherein the polymer has the following formula:

wherein p is 1 to 10,000;

m is 1 to 22;

X is —CH(OH)CH 2 OCH 2 CH 2 CH 2 S—;

n=0, 1, 2;

R is an alkyl group, and

R′ is alkyl group.

5. The particle of claim 4 , wherein the particle comprises a metal or metal oxide core.

6. The particle of claim 5 , wherein the particle has of an average core diameter of between 3 nm to 1000 nm.

7. The particle of claim 4 , wherein the terminal amine group is further conjugated to a targeting moiety.

8. The particle of claim 7 , wherein the targeting moiety is an antibody, antibody fragment, affibody, or peptide based ligand.

9. A particle having a siloxane coating of the formula:

wherein n is 1 to 10,000 and R is a siloxane connecting point to the surface of the particle.

10. A particle having a siloxane coating of the following formula:

wherein W is a targeting moiety, Z is a linking group, n is 1 to 10,000 and R is a siloxane connecting point to the surface of the particle.

11. A method of separating cells comprising

a) providing a contained area comprising nanoparticles,

wherein the nanoparticles have a siloxane coating of the following formula:

wherein W is a targeting moiety, Z is a linking group, n is 1 to 10,000, and R is a siloxane connecting point to the surface of the nanoparticles;

b) mixing the nanoparticles with a mixture of cells comprising target cells and non-target cells, wherein target cells comprise a moiety that the targeting group binds under conditions such that the nanoparticles bind with target cells;

c) exposing the contained area to a magnetic field; and

d) moving the non-target cells such that the target cells are restrained to the magnetic field thereby separating non-target cells from target cells.

12. A method detecting the presence of a cell in a confined area of a subject comprising

a) administering a composition comprising nanoparticles under conditions such that the nanoparticles bind to target cells,

wherein nanoparticles have a siloxane coating the following formula:

wherein W is a targeting moiety, Z is a linking group, n is 1 to 10,000, and R is a siloxane connecting point to the surface of the nanoparticles;

b) exposing the confined area to magnetic field; and

c) detecting the presence of the nanoparticles in the confined area.

Assignments (2)
CONFIRMATORY LICENSE Recorded May 4, 2020
From: EMORY UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 052559/0584 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 28, 2019
From: MAO, HUI; LI, YUANCHENG; YANG, LILY
To: EMORY UNIVERSITY
Reel/Frame 048730/0754 →
Continuity (2)
Provisional Application 62317239 · Apr 1, 2016
Related Publication 20170285020A1 · Oct 5, 2017